Provided By GlobeNewswire
Last update: Jun 4, 2025
PHILADELPHIA and VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces today that the Company will be conducting two virtual investor presentations on Thursday, June 12, at 12:00 PM EDT and on Thursday, June 26, at 12:00 PM EDT, arranged by Renmark Financial Communications Inc. Briacell Therapeutics Corp. welcomes stakeholders, investors, and other individual followers to register and attend these live events.
Read more at globenewswire.comNASDAQ:BCTXZ (11/6/2025, 8:00:01 PM)
0.331
-0.03 (-8.08%)
NASDAQ:BCTX (11/6/2025, 8:00:01 PM)
9.83
-0.39 (-3.82%)
NASDAQ:BCTXW (11/6/2025, 8:00:01 PM)
0.0484
0 (-1.63%)
Find more stocks in the Stock Screener


